An Office of National Drug Control Policy report concludes cocaine use fell by 50 percent between 2006 to 2010. But increases in heroin use should still alarm taxpayers whose money in public goods is diverted from other uses.
Read more →2000-2010 may mark drug data’s golden era as the federal government has cut back funding for collecting drug use data, curtailing research opportunities.
Read more →Hard drug users get “cold feet” answering national survey. Recent RAND drug policy researcher reveals the discrepancy between recorded and actual use, is near double.
Read more →Electronics and appliances, sporting goods, and even bar culture can’t compete with amount of money Americans spent on meth, marijuana, heroin and cocaine in 2010, according to the recently released RAND Corporation study. The American appetite for illegal drugs is profound. And with no policy to curtail demand, despite 43 years of the War...
Read more →The US has “fallen out of love with cocaine” writes the International Business Times. The States new love-interest: marijuana. The RAND Drug Policy Research Centre study concludes that Marijuana’s increase is due to “daily use” among the population. The study shows that over the last decade Americans have spent over a trillion dollars to...
Read more →Marijuana use, whether recreational or medicinal, has been on the rise, concludes a recent study–even before legalization in Colorado and Washington. The drug’s health effects remain unclear because the study of cannabis has been restricted due to federal law. With over two decades to study the effects of its over 100 active compounds, the...
Read more →A meager 2 percent of the American population account for heavy marijuana consumption that drives much of the national increase. But with recent federal cuts to the Arrestee Drug Abuse Monitoring program, estimates and future monitoring, seem destined for greater conjecture.
Read more →Potential marijuana licensees are apprehension for many reasons. Washington will announce the first licensee March 5 and nobody wants the be the target of that ire. But there are other concerns. The prime time to plant crops is mid-March, so there is the argument that outdoor growers should be given precedence. Turnstile legislation and...
Read more →Dr. Kleiman forebodes how the damages inherent in marijuana commercialization pursued by Washington and Colorado will empower anti-legalization advocates and aggravate social ills. The marijuana industry’s market will naturally target those already afflicted with substance abuse disorders; sustaining the problems this involves. If the state isn’t capable of addressing these concern he argues, regulation...
Read more →There is little debate that federal sanctions, making it near impossible to conduct clinical trials, continue to impair the scientific community’s understanding of marijuana. An understanding that becomes crucial at a time when states must grapple with setting policies that can impact driver-safety and substance abuse treatment.
Read more →